Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study

@inproceedings{Morrisroe2016RiskFF,
  title={Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study},
  author={Kathleen Morrisroe and Molla M Huq and Wendy M Stevens and Candice Rabusa and Susanna M Proudman and Mandana Nikpour and Catherine Hill and Sue Lester and G S Ngian and Susannah Proudman and Maureen Rischmueller and Janet Roddy and Jo Sahhar and Wendy Stevens and Gemma Strickland and Jennine Walker and Jane Zochling},
  booktitle={BMC pulmonary medicine},
  year={2016}
}
BACKGROUND Pulmonary arterial hypertension (PAH) is the leading cause of mortality in patients with systemic sclerosis (SSc). We sought to determine the incidence, prevalence and risk factors for PAH development in a large Australian SSc cohort. METHODS PAH was diagnosed on right heart catheterisation (mPAP >25 and PAWP <15 mmHg at rest). Patients with PH… CONTINUE READING